マサチューセッツ州における潰瘍性大腸炎の臨床試験
マサチューセッツ州内の拠点で、潰瘍性大腸炎に関する17件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/21更新 · NCT06420375A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
被験者募集中第2相
12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400017, Boston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
被験者募集中
18歳〜85歳 · 全性別 · 2026/01/08更新 · NCT05987852Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
被験者募集中第2相
18歳〜75歳 · 全性別 · 2025/10/20更新 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
被験者募集中観察研究
5歳〜25歳 · 全性別 · 2025/03/03更新 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
被験者募集中観察研究健康なボランティア歓迎
14歳以上 · 全性別 · 2024/12/20更新 · NCT06655415ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。